M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines

Brian Budzik, Yonghui Wang, Dongchuan Shi, Feng Wang, Haibo Xie, Zehong Wan, Chongye Zhu, James J. Foley, Parvathi Nuthulaganti, Lorena A. Kallal, Henry M. Sarau, Dwight M. Morrow, Michael L. Moore, Ralph A. Rivero, Michael Palovich, Michael Salmon, Kristen E. Belmonte, Dramane I. Laine, Jian Jin

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Exploration of multiple regions of a bi-aryl amine template led to the identification of highly potent M3 muscarinic acetylcholine receptor antagonists such as 14 (pA2 = 11.0) possessing good sub-type selectivity for M3 over M2. The structure-activity relationships (SAR) and optimization of the bi-aryl amine series are described.

Original languageEnglish
Pages (from-to)1686-1690
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number6
DOIs
StatePublished - 15 Mar 2009
Externally publishedYes

Keywords

  • Antagonists
  • Asthma
  • Bi-aryl amines
  • COPD
  • M mAChR
  • Muscarinic acetylcholine receptor
  • SAR
  • Sub-type selectivity

Fingerprint

Dive into the research topics of 'M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines'. Together they form a unique fingerprint.

Cite this